2017/01/01 by John R. Bartholomew · 1 citation
Medicine · #Venous Thromboembolism Diagnosis and Management #Atrial Fibrillation Management and Outcomes #Case Reports on Hematomas #Medicine #Pulmonary embolism #Deep vein #Venous thromboembolism #Thrombosis #Chest pain #Intensive care medicine #Venous thrombosis #Surgery
paper · pdf · doi:10.3949/ccjm.84.s3.04
openalex publication_date 2017/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism, is a common cardiovascular disease associated with significant morbidity ranging from painful leg swelling, chest pain, shortness of breath, and even death. Long-term complications include recurrent VTE, postpulmonary embolism syndrome, chronic thromboembolic pulmonary hypertension, and postthrombotic syndrome (PTS). Management of VTE requires immediate anticoagulation therapy based on a risk assessment for bleeding. Direct oral anticoagulants (DOACs) have become an important option for patients as reflected in the most recent American College of Chest Physician treatment guidelines.